Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Grown Rogue International's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grown Rogue International OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Grown Rogue International's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Grown Rogue International's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grown Rogue International (FRA:1VF0) has a OCF Margin % of 27.69% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Grown Rogue International and its competitors. This is 661% above median its historical median of 3.64. According to the industry distribution chart, Grown Rogue International ranks #175 out of 964 companies in the Drug Manufacturers industry, placing it in the top 18.2%.
Is Grown Rogue International's OCF Margin % too high?
Grown Rogue International's current OCF Margin % of 27.69% is 661% above median its 10-year median of 3.64. The Drug Manufacturers industry median OCF Margin % is 10.03. Grown Rogue International's value of 27.69% is 176.2% above this industry median. Based on the distribution chart, Grown Rogue International ranks #175 out of 964 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Grown Rogue International has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Grown Rogue International's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Grown Rogue International ranks #175 out of 964 companies for OCF Margin %. This places Grown Rogue International in the top 18% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 10.03. Grown Rogue International's value of 27.69% is 176.2% above this benchmark. While the company's 10-year median is 3.64 vs. the industry median of 10.03, Grown Rogue International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.03, based on 964 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grown Rogue International's current OCF Margin % of 27.69% is 176.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Grown Rogue International and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grown Rogue International's current OCF Margin % is 27.69%, which is 661% above median its own 10-year median of 3.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grown Rogue International stock overvalued right now?
Grown Rogue International (FRA:1VF0) has a current OCF Margin % of 27.69%. The stock's GF Value™ is €0.36, compared to a current price of €0.36 — trading 0.6% below its estimated fair value. The current OCF Margin % is 27.69%, which is 661% above median its 10-year median of 3.64 and 176.2% above the Drug Manufacturers industry median of 10.03. Grown Rogue International's overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Grown Rogue International (FRA:1VF0), the current OCF Margin % is 27.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Grown Rogue International (FRA:1VF0) Overvalued in 2026?
Based on GuruFocus' analysis, Grown Rogue International stock appears to be undervalued.
The current stock price of €0.36 is trading 0.6% below its estimated GF Value™ of €0.36.
Key valuation signals for FRA:1VF0:
OCF Margin %: 27.69% (661% above median its 10-year median of 3.64)
GF Value™: €0.36 vs. price of €0.36 (0.6% below fair value)
Industry Position: 176.2% above the Drug Manufacturers median (#175 of 964)
No single metric tells the full story. See the FRA:1VF0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Grown Rogue International Inc is engaged in the business of growing and selling cannabis products. Its primary cannabis product produced and sold is cannabis flower. Geographically, the company generates a majority of its revenue from the United States. The company has identified three operating segments: the Oregon segment represents cannabis production and sales activities in Oregon; the Michigan segment represents cannabis production and sales activities in Michigan; and the New Jersey segment represents cannabis production and sales activities in New Jersey.
49GF Score
Get the complete analysis for FRA:1VF0
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1VF0 has been successfully added to your 
